Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis

Acta Neuropathologica(2022)10.1007/s00401-022-02450-3Source: DataRank Database

Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis is a research paper published in Acta Neuropathologica (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 1.73)OA: hybridTopics (66)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Emily C. Wheeler ORCID,Martin Regensburger ORCID,Tom Boerstler ORCID,Holger Wend,Anthony Q. Vu ORCID

Live enrichment

PubMed:35778567 OpenAlex:https://openalex.org/W4283741487

Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Erlangen

Grant: P054

Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Erlangen

Grant: J88

Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Erlangen

Grant: E30

BaCaTeC

Grant: A5[2019-02]

Bayerisches Staatsministerium für Bildung und Kultus, Wissenschaft und Kunst

Grant: ForInter

Bundesministerium für Bildung und Forschung

Grant: 01GM1905B

Deutsche Forschungsgemeinschaft

Grant: WI 3567/2-1

Deutsche Forschungsgemeinschaft

Grant: 270949263/GRK2162

National Institute of Neurological Disorders and Stroke

Grant: R01NS088578

National Institute of Neurological Disorders and Stroke

Grant: R21NS121805

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1R21NS121805-01

ELAVL3 in ALS/FTD

National Institutes of Health

Grant: 5P30NS047101-07

project 1

National Institutes of Health

Grant: 5R01NS088578-02

Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD

FWCI

1.73

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00401-022-02450-3.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00401-022-02450-3.pdf

publisherhttps://link.springer.com/article/10.1007/s00401-022-02450-3/fulltext.html

journalhttps://doi.org/10.1007/s00401-022-02450-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35778567

Fields of Study

RNA Research and SplicingAmyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

RNA Splicing FactorsNeuro-Oncological Ventral AntigenAmyotrophic Lateral SclerosisAnimalsDNA-Binding ProteinsHumansNerve Tissue ProteinsNuclear ProteinsRepressor ProteinsRNA-Binding ProteinsAlternative SplicingMiceInduced Pluripotent Stem Cells

Keywords

Amyotrophic lateral sclerosisRNA splicingBiologyInduced pluripotent stem cellSplicing factorCell biologyLoss functionAlternative splicingRNA-binding proteinRNAPathologyDiseaseMedicineGeneticsGeneExonEmbryonic stem cellPhenotype570Clinical SciencesInduced Pluripotent Stem Cells610Nerve Tissue ProteinsNeurodegenerativeMedical and Health SciencesMiceRare DiseasesNeuro-Oncological Ventral Antigen2.1 Biological and endogenous factorsAnimalsHumansAetiologyOriginal PaperNeurology & NeurosurgeryBiomedical and Clinical SciencesStem Cell Research - Induced Pluripotent Stem CellStem Cell Research - Induced Pluripotent Stem Cell - HumanNeurosciencesNuclear ProteinsRNA-Binding ProteinsStem Cell ResearchBrain DisordersDNA-Binding ProteinsRepressor ProteinsNeurologicalRNA Splicing FactorsALS

Sustainable Development Goals

SDG 0: Good health and well-being